[Effect of 14-membered ring macrolides on heparanase mRNA expression in lung cancer cells].
Sasaki
M
M
Ito
T
T
Fukui
S
S
Izumiyama
N
N
Kashima
M
M
Sano
M
M
Fujiwara
Y
Y
Miura
H
H
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002465:Cell Movement / Q000187:drug effects; D017291:Clarithromycin / Q000494:pharmacology*; D004917:Erythromycin / Q000494:pharmacology*; D016222:Fibroblast Growth Factor 2 / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology; D015870:Gene Expression / Q000187:drug effects; D005966:Glucuronidase / Q000235:genetics / Q000378:metabolism*; D017228:Hepatocyte Growth Factor / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism* / Q000473:pathology; D010982:Platelet-Derived Growth Factor / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D000099175:Heparanase
D000900:Anti-Bacterial Agents; D017291:Clarithromycin; D004917:Erythromycin; D016222:Fibroblast Growth Factor 2; D005966:Glucuronidase; D017228:Hepatocyte Growth Factor; D010982:Platelet-Derived Growth Factor; D012333:RNA, Messenger; D000099175:Heparanase